Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hospice × Psilocybin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Neoplasms 7 Depression 7 Anxiety Disorders 6 Neoplasm Metastasis 3 Wounds and Injuries 1 Trauma, Nervous System 1 Stress Disorders, Post-Traumatic 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Opioid-Related Disorders 1 Melanoma 1 Lymphoma 1 Hospice 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Endocrine Gland Neoplasms 1 Depressive Disorder, Major 1 Depressive Disorder 1 Caregiver Distress 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Agnosia 1

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡